Early treatment in migraine: how strong is the current evidence?

Cephalalgia : an International Journal of Headache
A Gendolla

Abstract

Over the last 10 years, triptans (serotonin 5-HT(1B/1D) receptor agonists) have proved to be efficacious in treating migraine pain. However, recent evidence suggests that patients are still not receiving optimal pain management, particularly in clinical trials, where triptan treatment is generally not initiated until pain has reached moderate intensity. Pathophysiological evidence indicates that if treatment is initiated at an early stage, while pain is still mild and before the onset of central sensitization, outcomes for patients may be improved. In addition, a small number of clinical trials have been reported in which triptans were taken early (within 1 h of pain onset) or while pain was still mild; although constraints of trial design and data analysis limit definite conclusions, overall the results suggest that this early/mild approach results in more rapid and sustained pain relief. New studies are therefore needed to clarify the clinical benefits of early treatment, whilst taking into account potential risks, such as medication overuse. Ultimately, migraine treatment strategies require optimization in order to meet patient expectations and to reduce the current burden of migraine-associated disability.

References

Jul 7, 2000·Journal of Clinical Pharmacology·D Deleu, Y Hanssens
Nov 15, 2000·Cephalalgia : an International Journal of Headache·G M DaviesR Lipton
Feb 13, 2001·Cephalalgia : an International Journal of Headache·P Tfelt-HansenUNKNOWN International Headache Society Clinical Trials Subcommittee
Jan 5, 2002·Expert Opinion on Investigational Drugs·H C Diener, V Limmroth
Jan 25, 2002·The New England Journal of Medicine·Peter J GoadsbyMichel D Ferrari
Apr 23, 2002·Headache·Richard B LiptonJeffrey M Dayno
Jul 26, 2002·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·John Edmeads
Oct 18, 2002·Cephalalgia : an International Journal of Headache·M D FerrariR B Lipton
Oct 18, 2002·Cephalalgia : an International Journal of Headache·N C SantanelloR Lipton
Jan 6, 2004·Annals of Neurology·Rami BursteinMoshe Jakubowski
Jun 24, 2004·Headache·Ninan T MathewLori Meadors
Aug 3, 2004·Acta Neurologica Scandinavica·P J GoadsbyP Williams
Oct 16, 2004·Cephalalgia : an International Journal of Headache·M D Ferrari
Oct 16, 2004·Cephalalgia : an International Journal of Headache·J KlapperUNKNOWN ZODIAC study group
Oct 16, 2004·Cephalalgia : an International Journal of Headache·J ScholppN Banik
Dec 15, 2004·Cephalalgia : an International Journal of Headache·S D Silberstein
Dec 15, 2004·Cephalalgia : an International Journal of Headache·Rm Gallagher
Mar 4, 2005·Current Neurology and Neuroscience Reports·Frederick R Taylor
Aug 20, 2005·Cephalalgia : an International Journal of Headache·J L BrandesC R Sikes
May 31, 2006·Headache·Roger CadyFranck Skobieranda
Jun 30, 2006·International Journal of Clinical Practice·A J DowsonJ Pascual
Jul 13, 2006·Expert Review of Neurotherapeutics·Domenico D'AmicoGennaro Bussone
Nov 3, 2006·Headache·David Dodick, Stephen Silberstein
Nov 23, 2006·Headache·William Pryse-PhillipsKeith Wilson
Feb 16, 2007·Headache·Ninan T MathewUNKNOWN AEGIS Investigator Study Group
Jan 12, 2012·Cephalalgia : an International Journal of Headache·M Lantéri-MinetB Allaf

❮ Previous
Next ❯

Citations

Dec 21, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Marco SimonettoGiovanni Masè
Sep 16, 2010·Current Treatment Options in Neurology·Alan K Cole, Michael J Marmura
Sep 6, 2008·Cephalalgia : an International Journal of Headache·P J Goadsby
Sep 6, 2008·Cephalalgia : an International Journal of Headache·D W Dodick
Jun 30, 2010·International Journal of Clinical Practice·M Lanteri-MinetUNKNOWN START Study
May 29, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Gianni AllaisChiara Benedetto
Mar 2, 2010·Expert Review of Neurotherapeutics·Fabio AntonaciMarta Allena
Oct 15, 2010·Expert Review of Neurotherapeutics·Julio PascualCaroline C McGown
Mar 7, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Julie H Y HuangSteven P Cohen
Sep 22, 2010·Cephalalgia : an International Journal of Headache·Josh TorgovnickEdward Arsura
Aug 20, 2014·Cephalalgia : an International Journal of Headache·Peer Tfelt-Hansen
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Christopher J DerryR Andrew Moore
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Christopher J DerryR Andrew Moore
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Christopher J DerryR Andrew Moore
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Christopher J DerryR Andrew Moore
May 23, 2014·The Cochrane Database of Systematic Reviews·Sarah BirdR Andrew Moore
May 29, 2014·The Cochrane Database of Systematic Reviews·Christopher J DerryR Andrew Moore
May 2, 2013·The Cochrane Database of Systematic Reviews·Varo KirthiR Andrew Moore
May 2, 2013·The Cochrane Database of Systematic Reviews·Roy RabbieR Andrew Moore
May 29, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Gianni AllaisChiara Benedetto
Nov 20, 2018·Cephalalgia : an International Journal of Headache·Denise E ChouJean Schoenen

❮ Previous
Next ❯

Software Mentioned

AwM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.